Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C5 Isovaleryl/2-methylbutyryl (acylcarnitine)

Immunology & Autoimmune

C5Isovalerylcarnitine (C5)

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the C5 acylcarnitine in your blood, specifically the isovaleryl and 2-methylbutyryl forms. These molecules form when your body processes the amino acids leucine and isoleucine and then attaches them to carnitine for transport. Measuring C5 helps assess how well certain enzymes in these metabolic pathways are working.

C5 acylcarnitine is part of expanded metabolic screening panels and targeted evaluations for inborn errors of metabolism. It can be checked in newborns as part of follow-up testing, and in children or adults when a metabolic disorder is suspected. Results are interpreted together with other acylcarnitines, urine organic acids, and sometimes genetic testing.

Why it matters

Abnormal C5 levels can point to conditions that affect how the body breaks down specific amino acids. Elevated results may suggest isovaleric acidemia or short/branched-chain acyl-CoA dehydrogenase deficiency, conditions that can cause illness during stress or fasting if not recognized. Identifying these problems early helps prevent complications by guiding diet, supplements, and emergency sick-day care.

Clinicians order this test to confirm an abnormal newborn screen, investigate unexplained vomiting, lethargy, acidosis, or low blood sugar, or to monitor known metabolic disorders. It can also help distinguish between primary metabolic disease and temporary changes from diet, illness, or certain medicines.

Understanding your results

Your result will be reviewed in the context of age, symptoms, and other lab findings. A higher C5 value can be a clue to a metabolic condition, but it does not make a diagnosis by itself. Follow-up may include a full acylcarnitine profile, urine organic acids and acylglycines, and sometimes genetic testing of the IVD or ACADSB genes. If a disorder is confirmed, your care team may discuss dietary adjustments, carnitine or glycine supplementation, and plans for times of illness.

If your C5 value is typical for your age, no specific action is usually needed. If it is borderline or unexpectedly high, your clinician may repeat the test when you are well and fasting, or review medications and diet. For newborns, maternal health and feeding status can influence results, so both infant and maternal factors may be considered when planning next steps.

Reference ranges

0.050.2 umol/L
All sexes
0 days – 7 days
00.2 umol/L
All sexes
7 days – 1 month
00.21 umol/L
All sexes
1 month – 12 months
0.060.26 umol/L
All sexes
12 months – 13 years
0.050.23 umol/L
All sexes
13 years – 19 years
0.060.24 umol/L
All sexes
19 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C5 Isovaleryl/2-methylbutyryl (acylcarnitine)

  • Fasting and illness

    Recent fasting, fever, or acute illness can raise acylcarnitines by increasing fat and protein breakdown. Testing when you are well and fasting as instructed helps avoid misleading elevations.

  • Diet and supplements

    High protein intake, specialized formulas, or carnitine supplements can influence acylcarnitine patterns. Share details on diet, medical formulas, and any over-the-counter products with your clinician.

  • Medications

    Some medicines, such as valproate or certain antibiotics, can alter carnitine metabolism and acylcarnitine profiles. Provide a full medication list, including recent courses, before testing.

  • Sample timing in newborns

    In the first days of life, feeding transitions and maternal factors can affect infant acylcarnitines. Repeat testing after feeding stabilizes may clarify whether a change is persistent.

  • Primary vs secondary changes

    Low carnitine levels from prematurity, malnutrition, or maternal deficiency can modify acylcarnitine results. Measuring free carnitine and related markers can help separate primary disease from secondary effects.

  • Weight loss and ketogenic diets

    Active weight loss or use of ketogenic or very low carbohydrate diets increases fat oxidation and can shift acylcarnitine profiles. Discuss recent dietary changes before interpreting results.

2026

References

  1. McGill University Health Centre. (2019, June 07). C5 Isovaleryl_2methylbutyryl (Task CD 709460). Laboratory reference ranges.
  2. American College of Medical Genetics and Genomics. (2022). ACT sheet: Elevated C5 acylcarnitine. ACMG.
  3. Vockley, J., Burton, B. K., Berry, G. T., Longo, N., Phillips, J., Sanchez-Valle, A., & Zytkovicz, T. H. (2019). Diagnosis and management of isovaleric acidemia: Clinical practice resource of the American College of Medical Genetics and Genomics. Genetics in Medicine, 21(3), 631-643.
  4. Spiekerkoetter, U., Lindner, M., Santer, R., & Baumgartner, M. R. (2010). Management and outcome in 75 individuals with short/branched-chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism, 101(3), 233-239.